.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Covington
McKesson
Julphar
Daiichi Sankyo
Johnson and Johnson
Accenture
Chinese Patent Office
McKinsey
Merck

Generated: December 18, 2017

DrugPatentWatch Database Preview

Maprotiline hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for maprotiline hydrochloride and what is the scope of maprotiline hydrochloride freedom to operate?

Maprotiline hydrochloride
is the generic ingredient in two branded drugs marketed by Novartis, Am Therap, Mylan, Watson Labs, and Watson Labs Teva, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for maprotiline hydrochloride. One supplier is listed for this compound.

Medical Subject Heading (MeSH) Categories for maprotiline hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson LabsMAPROTILINE HYDROCHLORIDEmaprotiline hydrochlorideTABLET;ORAL071943-001Dec 30, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
NovartisLUDIOMILmaprotiline hydrochlorideTABLET;ORAL017543-003Sep 30, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Am TherapMAPROTILINE HYDROCHLORIDEmaprotiline hydrochlorideTABLET;ORAL072129-001Jan 14, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs TevaMAPROTILINE HYDROCHLORIDEmaprotiline hydrochlorideTABLET;ORAL072163-001Jun 1, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson LabsMAPROTILINE HYDROCHLORIDEmaprotiline hydrochlorideTABLET;ORAL071944-001Dec 30, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson LabsMAPROTILINE HYDROCHLORIDEmaprotiline hydrochlorideTABLET;ORAL071945-001Dec 30, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
MylanMAPROTILINE HYDROCHLORIDEmaprotiline hydrochlorideTABLET;ORAL072285-003Oct 3, 1988RXNoNo► Subscribe► Subscribe► Subscribe
Am TherapMAPROTILINE HYDROCHLORIDEmaprotiline hydrochlorideTABLET;ORAL072131-001Jan 14, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
NovartisLUDIOMILmaprotiline hydrochlorideTABLET;ORAL017543-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
MylanMAPROTILINE HYDROCHLORIDEmaprotiline hydrochlorideTABLET;ORAL072285-002Oct 3, 1988RXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Cipla
Novartis
Accenture
Chinese Patent Office
Merck
Baxter
QuintilesIMS
Federal Trade Commission
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot